123 related articles for article (PubMed ID: 18416104)
1. [Use of pantoprazol for treatment of gastroesophageal reflux disease and NSAID-induced gastropathy].
Pakhomova IG
Eksp Klin Gastroenterol; 2007; (6):110-5. PubMed ID: 18416104
[No Abstract] [Full Text] [Related]
2. [Preparation sanpraz (pantoprazole): experience of application in treatment of gastroesophageal reflux disease and other acid related diseases].
Sharova EP
Eksp Klin Gastroenterol; 2008; (6):74-6. PubMed ID: 19334429
[No Abstract] [Full Text] [Related]
3. [The quality of life dynamics in patients with gastroesophageal reflux disease during rabeprazol therapy].
Maev IV; Samsonov AA; Odintsova AN; Golubev NN; Iablunovskaia GI
Eksp Klin Gastroenterol; 2009; (4):97-100. PubMed ID: 19967818
[TBL] [Abstract][Full Text] [Related]
4. [Results of the treatment of duodenal ulcer associated with Helicobacter pylori and combined with gastroesophageal reflux disease].
Vasil'ev IuV; Nikol'skaia KA
Eksp Klin Gastroenterol; 2005; (6):61-4. PubMed ID: 17378390
[No Abstract] [Full Text] [Related]
5. [Using sunpraz in GERD].
Antipina TV; Merkulova SA; Dobrochasova NM; Guseva MV; Tkacheva AG
Eksp Klin Gastroenterol; 2008; (3):94-6. PubMed ID: 19145888
[No Abstract] [Full Text] [Related]
6. [Treatment of NSAIDs induced ulcers].
Mizokami Y; Shiraishi T; Otsubo T; Nakamura H; Miyazawa K; Narushima K; Matsuoka T
Nihon Rinsho; 2002 Feb; 60 Suppl 2():567-71. PubMed ID: 11979847
[No Abstract] [Full Text] [Related]
7. [Therapy of non-steroidal antirheumatic drug-induced gastrointestinal lesions with misoprostol].
Bach GL; Stock KP; Hüdepohl M
Z Rheumatol; 1991; 50(3):175-80. PubMed ID: 1927064
[TBL] [Abstract][Full Text] [Related]
8. [Drug treatment and surgical indications in gastroesophageal reflux].
Pérez-Manauta J
Rev Gastroenterol Mex; 2007 Nov; 72 Suppl 2():13-6. PubMed ID: 18277473
[No Abstract] [Full Text] [Related]
9. [Helicobacter eradication in gastritis and ulcers. Causal therapy, prevention of stomach cancer].
MMW Fortschr Med; 2003 Aug; 145(33-34):54-5. PubMed ID: 14526576
[No Abstract] [Full Text] [Related]
10. [Comparative evaluation of the omeprasol and pantoprasol efficacy in treatment of gastropathy induced by non-steroid anti-inflammatory drugs in the patients with rheumatoid arthritis].
Zufarov PS; Iakubov AV; Salaeva DT
Lik Sprava; 2009; (3-4):44-9. PubMed ID: 19960588
[TBL] [Abstract][Full Text] [Related]
11. [Gastropathy caused by nonsteroidal anti-inflammatory agents].
Márquez-Murillo MF; Suazo J; Poo JL
Rev Invest Clin; 1997; 49(3):241-54. PubMed ID: 9380979
[TBL] [Abstract][Full Text] [Related]
12. [Analysis of actual costs in long-term therapy of reflux disease. Use of pantoprazole counts].
MMW Fortschr Med; 2008 Oct; 150(40):52-3. PubMed ID: 18990887
[No Abstract] [Full Text] [Related]
13. [Report from an international consensus conference in Maastricht. Management and treatment of Helicobacter pylori infection].
Sjölund K; Ljungh A
Lakartidningen; 2001 Mar; 98(11):1235-8. PubMed ID: 11293128
[No Abstract] [Full Text] [Related]
14. [Indications and use of omeprazole in esophago-gastro-duodenal diseases].
Martín de Argila C; Boixeda de Miquel D; Moreira Vicente V; García Plaza A
Rev Clin Esp; 1999 Nov; 199(11):729-39. PubMed ID: 10638238
[No Abstract] [Full Text] [Related]
15. Non-steroidal anti-inflammatory drug gastropathy: clinical results with misoprostol.
Koch M
Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S54-62. PubMed ID: 10379471
[TBL] [Abstract][Full Text] [Related]
16. Treatment of peptic ulcer disease and nonulcer dyspepsia.
Meurer LN
J Fam Pract; 2001 Jul; 50(7):614-9. PubMed ID: 11485712
[No Abstract] [Full Text] [Related]
17. [Proton-pump inhibitor Rabeprazole: faster acid- and symptom-control].
Dtsch Med Wochenschr; 1998 Nov; 123(47 Suppl):1-4. PubMed ID: 9856116
[No Abstract] [Full Text] [Related]
18. [Omeprazole and misoprostol for NSAID-induced gastropathies: comparative efficiency of their short-term treatment].
Karateev AE; Murav'ev IuV
Klin Med (Mosk); 2001; 79(5):48-50. PubMed ID: 11510188
[TBL] [Abstract][Full Text] [Related]
19. [Long-term impact on quality of life in patients with gastroesophageal reflux disease after 52-week rabeprazole treatment].
Yang XL; Liu XH; Ke MY; Song ZQ; Yuan YZ; Luo JY; Hou XH
Zhonghua Yi Xue Za Zhi; 2009 Sep; 89(34):2404-7. PubMed ID: 20137694
[TBL] [Abstract][Full Text] [Related]
20. Clinical symptoms of FSSG in gastroesophageal reflux disease are critical for PPI treatment: Japanese multi-centers with 185 patients.
Komatsu-Tanaka M; Iwakiri R; Fujimoto K; Fujiwara Y; Inamori M; Tanaka J; Shimatani T; Akiyama J; Ando T; Manabe N; Kinjo F; Deguchi R; Kusano M
Dig Endosc; 2012 Nov; 24(6):407-11. PubMed ID: 23078431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
